You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mavenclad ®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine 10 mg oral tablet
  • Porto Alegre, RS, Brazil
    Pontifical Catholic University of Rio Grande do Sul
Jun 5, 2023

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Multiple Sclerosis Trial in Worldwide (Mavenclad®)

Completed
Has Results
  • Multiple Sclerosis
  • Sydney, New South Wales, Australia
  • +53 more
Jul 25, 2022

Multiple Sclerosis Trial in Worldwide (Mavenclad®)

Recruiting
  • Multiple Sclerosis
  • Liverpool, Australia
  • +46 more
Aug 23, 2021

Multiple Sclerosis Trial in Latham (Cladribine Tablets)

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022

Predictors in Clinical Practice (CLODINA)

Not yet recruiting
  • Multiple Sclerosis
  • Bruxelles, Belgium
  • +29 more
Mar 22, 2023

Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

Recruiting
  • Advanced Multiple Sclerosis
  • Progressive Multiple Sclerosis
  • Cladribine (MAVENCLAD®)
  • Placebo
  • Belfast, United Kingdom
  • +18 more
Jun 9, 2022

Multiple Sclerosis Trial in Worldwide (Mavenclad®)

Completed
  • Multiple Sclerosis
  • Linz, Austria
  • +91 more
Dec 16, 2021

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Active, not recruiting
  • Multiple Sclerosis
  • Alexandroupolis, Greece
  • +52 more
Sep 28, 2022

d in the Treatment of Multiple Sclerosis

Not yet recruiting
  • Multiple Sclerosis
  • Measurement of concentrations of orally-used DMDs
  • +3 more
  • Ostrava, Moravian-Silesian Region, Czechia
  • +1 more
Dec 5, 2022

Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
    • Coventry, United Kingdom
    • +7 more
    May 20, 2022

    Suboptimally Controlled Participants Previously Taking

    Active, not recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Cullman, Alabama
    • +38 more
    Jul 19, 2022

    Suboptimally Controlled Participants Previously Taking Oral or

    Recruiting
    • Multiple Sclerosis
    • Cladribine Tablets
    • Cullman, Alabama
    • +66 more
    Nov 29, 2022

    Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

    Recruiting
    • Atrial Fibrillation
    • Heart rhythm measurements with Preventicus®
    • +3 more
    • Genk, Limburg, Belgium
      Ziekenhuis Oost-Limburg
    Aug 28, 2023

    Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)

    Recruiting
    • Relapsing Multiple Sclerosis
    • Clinically Isolated Syndrome
    • San Francisco, California
      University of California San Francisco
    Apr 28, 2022

    ECMO Braile Biomédica® in COVID-19 Patients

    Recruiting
    • COVID-19
    • Patients underwent cardiorespiratory support
    • Lago Sul, Brasília - DF, Brazil
      Hospital Brasília
    Oct 13, 2023

    Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

    Not yet recruiting
    • Metastatic Gastric Adenocarcinoma
    • +2 more
    • nal-IRI /Experimental
    • +2 more
    • (no location specified)
    Jun 25, 2023

    Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

    Recruiting
    • Venous Leg Ulcer
    • Diabetic Foot
    • AQUACEL® Ag+ Extra™
    • Cutimed® Sorbact®
    • Barranquilla, Colombia
    • +13 more
    May 26, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in United States (Early Aggressive Therapy or Traditional Therapy)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Early Aggressive Therapy or Traditional Therapy
    • Birmingham, Alabama
    • +51 more
    Jan 23, 2023

    Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

    Recruiting
    • Dental Implants
    • Dynamic Computer Assisted Surgery
    • Freehand
    • L´hospitalet de Llobregat, Catalunya, Spain
      University of Barcelona
    Aug 31, 2023

    Carpal Tunnel Syndrome Trial in Denizli (KForce Sens, Baseline Electrigoniometer)

    Completed
    • Carpal Tunnel Syndrome
    • KForce Sens
    • Baseline Electrıgoniometer
    • Denizli, Turkey
      Pamukkale University
    Sep 14, 2023

    Tricuspid Regurgitation, Tricuspid Valve Disease Trial in Worldwide (TricValve® Transcatheter Bicaval Valve System, Medical

    Not yet recruiting
    • Tricuspid Regurgitation
    • Tricuspid Valve Disease
    • TricValve® Transcatheter Bicaval Valve System
    • Medical Therapy Arm
    • Cleveland, Ohio
    • +10 more
    Nov 14, 2023